Abstract
Chiral derivatives of two cyclohexylethyl halopyridyl thiourea compounds (HI-509 and HI-510), two α -methyl benzyl halopyridyl compounds (HI-511 and HI-512), and a cyclohexyl ethyl thiazolyl thiourea compound (HI-513) were synthesized and evaluated for their anti-cancer activity. Preliminary screening indicated that the (S)- isomers displayed improved activity in comparison with (R)- enantiomers to inhibit tubulin polymerization and activate caspase- 3. In accordance with these results, the thiourea derivatives displayed potent anti-cancer activity against human B-lineage (Nalm-6) and T-lineage (Molt-3) acute lymphoblastic leukemia cell lines. Based on the results we conclude that the anti-leukemic activity of these compounds also depends on their chirality.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 318-326 |
| Number of pages | 9 |
| Journal | Letters in Drug Design and Discovery |
| Volume | 4 |
| Issue number | 5 |
| DOIs | |
| State | Published - Jul 2007 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Caspase
- Leukemia
- Stereochemistry
- Thiourea
- Zebrafish
Fingerprint
Dive into the research topics of 'Stereochemistry as a determinant of the anti-leukemic potency of halopyridyl and thiazolyl thiourea compounds'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS